Free Trial
NASDAQ:VYGR

Voyager Therapeutics (VYGR) Stock Price, News & Analysis

Voyager Therapeutics logo
$3.28 +0.08 (+2.50%)
Closing price 07/3/2025 03:33 PM Eastern
Extended Trading
$3.20 -0.07 (-2.29%)
As of 07/3/2025 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Voyager Therapeutics Stock (NASDAQ:VYGR)

Key Stats

Today's Range
$3.17
$3.28
50-Day Range
$2.72
$3.64
52-Week Range
$2.65
$9.55
Volume
303,242 shs
Average Volume
481,437 shs
Market Capitalization
$181.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.39
Consensus Rating
Buy

Company Overview

Voyager Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
71st Percentile Overall Score

VYGR MarketRank™: 

Voyager Therapeutics scored higher than 71% of companies evaluated by MarketBeat, and ranked 263rd out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Voyager Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.13, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Voyager Therapeutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Voyager Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Voyager Therapeutics are expected to decrease in the coming year, from ($0.91) to ($1.59) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Voyager Therapeutics is -2.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Voyager Therapeutics is -2.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Voyager Therapeutics has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Voyager Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    7.57% of the float of Voyager Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Voyager Therapeutics has a short interest ratio ("days to cover") of 7.5.
  • Change versus previous month

    Short interest in Voyager Therapeutics has recently increased by 22.50%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Voyager Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Voyager Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.57% of the float of Voyager Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Voyager Therapeutics has a short interest ratio ("days to cover") of 7.5.
  • Change versus previous month

    Short interest in Voyager Therapeutics has recently increased by 22.50%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Voyager Therapeutics this week, compared to 4 articles on an average week.
  • Search Interest

    9 people have searched for VYGR on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Voyager Therapeutics to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Voyager Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.39% of the stock of Voyager Therapeutics is held by insiders.

  • Percentage Held by Institutions

    48.03% of the stock of Voyager Therapeutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Voyager Therapeutics' insider trading history.
Receive VYGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyager Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

VYGR Stock News Headlines

VYGR Voyager Therapeutics, Inc. - Seeking Alpha
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
See More Headlines

VYGR Stock Analysis - Frequently Asked Questions

Voyager Therapeutics' stock was trading at $5.67 on January 1st, 2025. Since then, VYGR stock has decreased by 42.2% and is now trading at $3.28.

Voyager Therapeutics, Inc. (NASDAQ:VYGR) issued its earnings results on Tuesday, May, 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.35) by $0.18. The company had revenue of $6.47 million for the quarter, compared to analyst estimates of $13.55 million. Voyager Therapeutics had a negative trailing twelve-month return on equity of 27.36% and a negative net margin of 126.49%.

Shares of VYGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Voyager Therapeutics investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AU Optronics (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/06/2025
Today
7/04/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VYGR
Fax
N/A
Employees
100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.39
High Stock Price Target
$30.00
Low Stock Price Target
$5.73
Potential Upside/Downside
+308.2%
Consensus Rating
Buy
Rating Score (0-4)
3.13
Research Coverage
8 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65 million
Net Margins
-126.49%
Pretax Margin
-125.46%

Debt

Sales & Book Value

Annual Sales
$80 million
Price / Cash Flow
N/A
Book Value
$5.49 per share
Price / Book
0.60

Miscellaneous

Free Float
51,800,000
Market Cap
$181.52 million
Optionable
Optionable
Beta
0.85

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:VYGR) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners